Literature DB >> 8611606

Serum independent liposome uptake by mouse liver.

F Liu1, D Liu.   

Abstract

The rate of liposome clearance from blood by the reticuloendothelial system (RES), primarily the Kupffer cells of the liver, depends largely on liposome composition. Inclusion of phosphatidylserine or dicetyl phosphate into liposomes with a simple composition of phosphatidylcholine and cholesterol increases liposome clearance, while inclusion of GM1 or amphipathic poly(ethylene glycol) decreases the rate of liposome clearance. To understand the underlying mechanism by which liposome clearance is regulated by the RES, we have developed a simple liver perfusion system. Using mouse liver as a model, we demonstrated that hepatic uptake of neutral or negatively charged liposomes does not involve serum components. Liver uptake of liposomes is directly related to the surface characteristics of liposomes. Liposomes with a neutral composition of phosphatidylcholine and cholesterol exhibit relatively low liver uptake. Inclusion of PS or DCP into these liposome dramatically enhances liposome uptake by the perfused liver. Conversely, inclusion of GM1 or PEG derivatives into liposomes greatly reduces the liposome uptake by the mouse liver. In contrast to the neutral or negatively charged liposomes, serum enhances the liver uptake of positively charged liposomes. Such serum effect on liver uptake of the positively charged liposomes is likely due to liposome aggregations caused by serum proteins. Inhibition of the liver uptake for PS-containing liposomes using liposomes with different compositions suggests that liver uptake of liposomes may involve different receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611606     DOI: 10.1016/0005-2736(95)00196-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Clearance and biodistribution of liposomally encapsulated nitroxides: a model for targeted delivery of electron paramagnetic resonance imaging probes to tumors.

Authors:  Scott R Burks; Eric A Legenzov; Gerald M Rosen; Joseph P Y Kao
Journal:  Drug Metab Dispos       Date:  2011-07-07       Impact factor: 3.922

3.  Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes.

Authors:  K Edwards; M Johnsson; G Karlsson; M Silvander
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

Review 4.  siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion.

Authors:  Worapol Ngamcherdtrakul; Wassana Yantasee
Journal:  Transl Res       Date:  2019-08-19       Impact factor: 7.012

5.  The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation.

Authors:  Natassa Pippa; Faidra Psarommati; Stergios Pispas; Costas Demetzos
Journal:  Pharm Res       Date:  2013-06-07       Impact factor: 4.200

6.  Antileishmanial activities of stearylamine-bearing liposomes.

Authors:  T Dey; K Anam; F Afrin; N Ali
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Cellular uptake of electron paramagnetic resonance imaging probes through endocytosis of liposomes.

Authors:  Scott R Burks; Eugene D Barth; Howard J Halpern; Gerald M Rosen; Joseph P Y Kao
Journal:  Biochim Biophys Acta       Date:  2009-08-25

8.  Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome).

Authors:  R M Fielding; R O Lewis; L Moon-McDermott
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

9.  Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells.

Authors:  Scott R Burks; Luciana F Macedo; Eugene D Barth; Katherine H Tkaczuk; Stuart S Martin; Gerald M Rosen; Howard J Halpern; Angela M Brodie; Joseph P Y Kao
Journal:  Breast Cancer Res Treat       Date:  2010-01-12       Impact factor: 4.872

Review 10.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.